COMPASS THERAPEUTICS, INC. (CMPX)
Clinical trial NCT07392957 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-31 → 2026-06-16 3. completion date: 2031-05-31 → 2031-06-30 4. primary completion date: 2029-05-31 → 2029-06-30
Clinical trial NCT07392957 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-31 → 2026-06-16 3. completion date: 2031-05-31 → 2031-06-30 4. primary completion date: 2029-05-31 → 2029-06-30
Clinical trial NCT05071144: collaborators removed: Cedars-Sinai Medical Center.
Clinical trial NCT05095051 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2023-09-01 → 2023-07-05 3. primary completion date: 2023-09-01 → 2023-07-05 4. enrollment: 33 → 15 participants 5. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT05742750: enrollment: 48 → 49 participants.
Clinical trial NCT03476681 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2029-01-15 → 2026-11-30 3. primary completion date: 2028-01-15 → 2026-06-17
Clinical trial NCT05607719 updates: 1. completion date: 2026-06-30 → 2026-07-31 2. primary completion date: 2026-06-30 → 2026-07-31
Clinical trial NCT06090539: enrollment: 308 → 460 participants.
Clinical trial NCT07504601: start date: 2026-06-23 → 2026-06-24.
Clinical trial NCT05756777 updates: 1. start date: 2023-06-26 → 2023-10-25 2. completion date: 2027-02-01 → 2027-04-21 3. primary completion date: 2027-02-01 → 2027-04-21
Clinical trial NCT06723795: status: RECRUITING → ACTIVE_NOT_RECRUITING.